Athens, OH, United States of America

Mehmet Celenk

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ohio University. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Mehmet Celenk in Diabetic and Macular Degeneration Detection

Introduction

Mehmet Celenk is an accomplished inventor based in Athens, Ohio. He has made significant contributions to the field of medical technology, particularly in the detection of diabetic and macular degeneration. His innovative work focuses on improving diagnostic methods that can lead to better patient outcomes.

Latest Patents

Celenk holds a patent for "Devices and methods for classifying diabetic and macular degeneration." This patent describes devices and methods for determining a propensity to diabetic and/or macular degeneration in a subject by measuring certain features from a captured retinal image. His work in this area is crucial for early detection and intervention in these serious health conditions.

Career Highlights

Celenk is affiliated with Ohio University, where he continues to advance his research and development efforts. His dedication to innovation in medical technology has positioned him as a key figure in his field. With 1 patent to his name, he exemplifies the spirit of invention that drives progress in healthcare.

Collaborations

Celenk has collaborated with notable colleagues, including H Bryan Riley and Nikita Gurudath. These partnerships enhance the scope and impact of his research, fostering an environment of innovation and discovery.

Conclusion

Mehmet Celenk's contributions to the detection of diabetic and macular degeneration highlight the importance of innovation in medical technology. His work not only advances scientific understanding but also has the potential to improve the lives of many individuals affected by these conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…